Loading provider…
Loading provider…
Surgery Physician in Tampa, FL
NPI: 1225069313Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get MD, PHD Sophie's Phone Numberphone_androidMobile
Get MD, PHD Sophie's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2001 - 2027

American Board of Surgery
Surgery
University of South Florida Morsani/Moffitt Cancer Center
Fellowship • Complex General Surgical Oncology
1999 - 2001
Dalhousie University Faculty of Medicine
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 59 | 74 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 19 | 19 |
| 3 | 11106Incisional biopsy of single skin lesion | 12 | 12 |
| 4 | 11107Incisional biopsy of additional skin lesion | 11 | 30 |
Authors: Jonathan Greer, Sean Dineen, Travis Grotz, Andrew Blakely, Joel Baumgartner, David Roife, Callisia Clarke, Daniel Abbott, Jordan Cloyd, Byrne Lee, Laura Lambert, Jula Veerapong, Keith Fournier, Mohammad Zaidi, Ahmed Ahmed
Journal: Ann Surg Oncol
Publication Date: 2020-10-18
A Phase I Study of Adenovirus Mediated Gene Transfer of Interleukin 2 cDNA into Metastatic Breast Cancer or Melanoma. The Toronto Hospital, Toronto, Ontario, Canada
Authors: A. K. Stewart, N. J. Lassam, Frank L. Graham, Jack Gauldie, Christina L. Addison, Denis Bailey, Sophie Dessureault, Ian D. Dubé, S. Gallenger, M. Krajden, Lorne E. Rotstein, I. C. Quirt, Moen Rc
Publication Date: 1997-07
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Cancer Institute (NCI), American Society of Clinical Oncology, Society of Surgical Oncology (SSO)
Intervention / Treatment: BIOLOGICAL: Bystander-Based Autologous Tumor Cell Vaccine
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Cancer Institute (NCI), Novartis, Lymphoma Research Foundation
Intervention / Treatment: DRUG: Doxorubicin, DRUG: Dexamethasone, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Vincristine, DRUG: IL-2, BIOLOGICAL: Autologous Tumor Cell-Based Vaccine